HealthDay

Low-income patients in intervention group reported higher quality of care, spent fewer days in hospital

Significant associations observed between psoriasis and risk for Crohn’s disease, ulcerative colitis

Higher risk seen with ACEIs versus angiotensin receptor blockers; risk linked to duration of use

Correlation between metabolite level of dibutyl phthalate, butyl benzyl phthalate and language delay

Survival benefit persists through five years from the time of offer for an increased-risk donor allograft

Many patients with peripheral artery disease smoke; just 16 percent referred to cessation counseling

Hispanic, other race/ethnicity; age at time of study; low testosterone levels were risk factors for ED

The 60th Annual Meeting of the American Society for Radiation Oncology The annual meeting of the American Society for Radiation Oncology was held from Oct. 21 to 24 in San Antonio, Texas, and attracted approximately 11,000 participants from around the world, including physicians, oncology nurses, radiation therapists, biologists, physicists, and other cancer researchers. The conference […]

Those with diabetes, depressive symptoms in peer support intervention had lower rate of hospitalization

Competitive grant initiative aims to promote change in graduate medical education

Both overall and progression-free survival longer with durvalumab than with placebo

New multidisciplinary guideline for early-stage prostate cancer developed by three professional societies

Among children with ASD, those with severe symptoms more likely to be overweight/obese

After free flap surgery, smoking status tied to wound disruption, unplanned reoperation

More patients receiving nurse-led care had serum urate concentrations less than 360 µmol/L at 2 years

Several breastfeeding outcomes consistently improved for married, white, high-income mothers

Colorectal cancer patients with healthy diets pre- or post-diagnosis have longer survival

Survival at 1 year was 91.7 percent with home dialysis versus 81.4 percent with in-center dialysis

Results from phase 2 study in patients with multidrug-resistant Gram-negative uropathogens